Overview

Intranasal Oxytocin in the Treatment of Autism

Status:
Completed

Trial end date:
2012-04-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to learn whether or not the drug called oxytocin is helpful in improving mood and social functioning in adults with autism.

Phase:

Phase 2

Details

Lead Sponsor:

Evdokia Anagnostou

Collaborator:

Icahn School of Medicine at Mount Sinai

Treatments:

Oxytocin